Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Essentials of 3D Biofabrication and Translation
    Unavailable
    Essentials of 3D Biofabrication and Translation
    Unavailable
    Essentials of 3D Biofabrication and Translation
    Ebook1,485 pages15 hours

    Essentials of 3D Biofabrication and Translation

    By Anthony Atala and James J Yoo

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Essentials of 3D Biofabrication and Translation discusses the techniques that are making bioprinting a viable alternative in regenerative medicine.

    The book runs the gamut of topics related to the subject, including hydrogels and polymers, nanotechnology, toxicity testing, and drug screening platforms, also introducing current applications in the cardiac, skeletal, and nervous systems, and organ construction.

    Leaders in clinical medicine and translational science provide a global perspective of the transformative nature of this field, including the use of cells, biomaterials, and macromolecules to create basic building blocks of tissues and organs, all of which are driving the field of biofabrication to transform regenerative medicine.

    • Provides a new and versatile method to fabricating living tissue
    • Discusses future applications for 3D bioprinting technologies, including use in the cardiac, skeletal, and nervous systems, and organ construction
    • Describes current approaches and future challenges for translational science
    • Runs the gamut of topics related to the subject, from hydrogels and polymers to nanotechnology, toxicity testing, and drug screening platforms
    LanguageEnglish
    PublisherAcademic Press
    Release dateJul 17, 2015
    ISBN9780128010150
    Unavailable
    Essentials of 3D Biofabrication and Translation
    Author

    Anthony Atala

    Anthony Atala, M.D., is the Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. His current work focuses on growing new human cells, tissues and organs. Dr. Atala works with several journals and serves in various roles, including Editor-in-Chief of Current Stem Cell Research and Therapy, and Therapeutic Advances in Urology; as Associate Editor of the Journal of Tissue Engineering and Regenerative Medicine, The Journal of Rejuvenation Research, Nanotechnology in Engineering and Medicine, Gene Therapy and Regulation, and Current Reviews in Urology; as Executive Board Member or Section Editor of the journal Tissue Engineering and International Journal of Artificial Organs, and as Editorial Board member of the International Journal of Stem Cells, Stem Cell Review Letters, Expert Opinion on Biological Therapy, Biomedical Materials, Recent Patents on Regenerative Medicine, the Journal of the American College of Surgeons, the Journal of Urology, BMC Urology, Urology, and Current Opinion in Urology. Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society, and the Gold Cystoscope Award for advances in his field. Dr. Atala was named by Scientific American as a Medical Treatments Leader of the Year for his contributions to the fields of cell, tissue and organ regeneration. In 2006, he was named by Fast Company magazine as one of 50 people who “will change how we work and live over the next 10 years. Dr. Atala’s work was listed as Discover Magazine`s Number 1 Top Science Story of the Year in the field of medicine, and as Time Magazine’s top 10 medical breakthroughs of the year in 2007. A Time Magazine poll ranked Dr. Atala as the 56th most influential person of the year in 2007. Esquire Magazine in 2008 named Dr. Atala one of the 75 most influential persons of the 21st century. Fast Company Magazine named Dr. Atala one of 100 Most Creative People in Business in 2009. Dr. Atala was featured in U.S. News & World Report as one of “14 Medical Pioneers Who Aren’t Holding Back.” Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, and the National Institutes of Health Bioengineering Consortium. He is currently an NIH “Quantum Grant” awardee. Dr. Atala heads a team of over 250 physicians and researchers. Ten applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is the editor of nine books, including Minimally Invasive Urology, Methods of Tissue Engineering, Principles of Regenerative Medicine, and Foundations of Regenerative Medicine, and has published more than 300 journal articles and has applied for or received over 200 national and international patents.

    Related to Essentials of 3D Biofabrication and Translation

    Related ebooks

    Science & Mathematics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: AI Will Revolutionize Drug Discovery — But Only If Experts Are Involved

      Nov 1, 2019

      To fruitfully apply AI to drug discovery, we need better feedback loops between developers and interdisciplinary teams that test the technology.

      4 min read

    • Article

      At $2.1 Million, Newly Approved Novartis Gene Therapy Will Be World’s Most Expensive Drug

      May 24, 2019

      The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most…

      4 min read

    • Article

      A Killing In Cannabis

      Mar 15, 2022

      A Killing In Cannabis
      31 min read

    • Article

      Treating Everyone Like Rock Stars

      Dec 24, 2020

      Treating Everyone Like Rock Stars
      1 min read

    • Article

      Does Aging Have a Reset Button?

      Feb 1, 2018

      Part of Vittorio Sebastiano’s job is to babysit a few million stem cells. The research professor of reproductive biology at Stanford University keeps the cells warm and moist deep inside the Lorry I. Lokey Stem Cell Research Building, one of the nati

      6 min read

    • Article

      Bitcoin Promises Filmmakers And Writers Tales Of Get-rich Fever And Cyber Intrigue

      Feb 13, 2018

      Nearly 10 years after bitcoin was invented, a cryptocurrency craze is sweeping the planet with the ferocity of a Trump tweet, inspiring songs, creating millionaires, unnerving banks and giving writers and filmmakers potent narratives of Gold Rush fev

      5 min read

    • Article

      The Power Of 2

      Mar 15, 2022

      The Power Of 2
      14 min read

    • Article

      Getting More from Less

      Dec 1, 2020

      Getting More from Less
      2 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opening The ‘Black Box,’ Google DeepMind AI System Diagnoses Eye Diseases And Shows Its Work

      Aug 13, 2018

      Experts said the level of accuracy is impressive, but the bigger breakthrough is the DeepMind system’s solution to the so-called “black box” problem of artificial intelligence.

      5 min read

    • Article

      The Future Is Here

      Nov 9, 2020

      The Future Is Here
      6 min read

    • Article

      Scientists Control Tiny ‘Factories’ In Engineered Cells

      Mar 7, 2018

      Researchers have discovered how to dynamically manage the allocation of essential resources inside engineered cells. The research could advance the potential of synthetically programming cells to combat disease and produce new drugs. They developed a

      2 min read

    • Article

      DeepMind AI Predicts Acute Loss Of Kidney Function Two Days In Advance, Study Shows

      Jul 31, 2019

      DeepMind's AI was able to predict 90% of acute kidney injury episodes that required dialysis, with a lead time of 48 hours.

      2 min read

    Related categories

    Reviews for Essentials of 3D Biofabrication and Translation

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words